Line extension [Design Issues]

posted by Mikkabel – Belgium, 2018-01-24 11:17 (2364 d 16:47 ago) – Posting: # 18285
Views: 4,426

❝ Luckily you are not exceeding the recommended dose of the originator. Hence, I would opt for a simple line extension (T2 vs. 2×T1) since you can expect a better match than in BE – which is possible as well (T2 vs. 2×R).

❝ I don’t see how you could perform a dose-proportionality study with just two levels (zero degrees of freedom).

Hi Helmut,

Thank you for your quick reply!

I would also opt for a simple Pk study (T2 versus 2*T1) but do you have any idea to which guidelines I can refer to justify the rationale of the study and in particular the choice of the comparator (T1 instead of the originator).

Regarding the dose proportional study, I meant a PK study (T1 vs T2) and the results corrected by the dose should be compared.

Kind regards,

Complete thread:

UA Flag
 Admin contact
23,101 posts in 4,857 threads, 1,644 registered users;
69 visitors (0 registered, 69 guests [including 6 identified bots]).
Forum time: 05:04 CEST (Europe/Vienna)

One can show the following: given any rule, however “fundamental”
or “necessary” for science, there are always circumstances
when it is advisable not only to ignore the rule,
but to adopt its opposite.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz